Skip to main content
Clinical Trials/NCT06300593
NCT06300593
Completed
Not Applicable

Evaluation of the Activity of Chronic Inflammation and Its Impact on Metabolic and Hormonal Parameters in Various PCOS Phenotypes

Jagiellonian University1 site in 1 country80 target enrollmentJanuary 15, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Polycystic Ovary Syndrome
Sponsor
Jagiellonian University
Enrollment
80
Locations
1
Primary Endpoint
Values of inflammation parameters - IL-1 in peripheral blood in the four PCOS phenotypes
Status
Completed
Last Updated
last year

Overview

Brief Summary

Chronic inflammation in polycystic ovary syndrome (PCOS) may be the result of dysregulation of cytokine production (due to insulin resistance, excess visceral fat and hyperandrogenemia), i.e., overproduction of pro-inflammatory factors (e.g. TNF, IL-1, IL-6) in relation to anti-inflammatory ones (IL-10). This condition may be an important link between obesity and insulin resistance, which is crucial in the etiopathogenesis of the syndrome. However, it is not known whether it results from the tendency to accumulate adipose tissue or is a feature of the syndrome itself. There is no data indicating the relationship between chronic inflammation and the severity of metabolic disorders and the value of ovarian reserve in women with various PCOS phenotypes.

Detailed Description

The study population will be characterized in terms of demographic (age, BMI), gynaecological (cycle length, menstrual pain, abnormal uterine bleeding) and obstetrics (pregnancies, childbirth, miscarriages) data. PCOS syndrome (and its phenotypes: A, B, C, D) will be recognized by the Rotterdam criteria. During hospitalization, blood samples will be collected for scheduled analyses (20 ml of blood in total).

Registry
clinicaltrials.gov
Start Date
January 15, 2024
End Date
June 30, 2024
Last Updated
last year
Study Type
Observational
Sex
Female

Investigators

Sponsor
Jagiellonian University
Responsible Party
Principal Investigator
Principal Investigator

Iwona Magdalena Gawron

Principal Investigator

Jagiellonian University

Eligibility Criteria

Inclusion Criteria

  • age 18-45 years
  • PCOS syndrome confirmed by the Rotterdam criteria

Exclusion Criteria

  • absence of at least one ovary
  • diagnosed and/or treated other metabolic disease
  • diagnosed and/or treated other endocrine disease

Outcomes

Primary Outcomes

Values of inflammation parameters - IL-1 in peripheral blood in the four PCOS phenotypes

Time Frame: up to 3 months

Measurement and comparison of concentrations of IL-1 (pg/ml) in peripheral blood in the four PCOS phenotypes

Values of inflammation parameters - IL-10 in peripheral blood in the four PCOS phenotypes

Time Frame: up to 3 months

Measurement and comparison of concentrations of IL-10 (pg/ml) in peripheral blood in the four PCOS phenotypes

Values of inflammation parameters - TNF-alpha in peripheral blood in the four PCOS phenotypes

Time Frame: up to 3 months

Measurement and comparison of concentrations of TNF-alpha (pg/ml) in peripheral blood in the four PCOS phenotypes

Values of inflammation parameters - leukocytosis in peripheral blood in the four PCOS phenotypes

Time Frame: up to 3 months

Measurement and comparison of leukocyte count (n/µL) in peripheral blood in the four PCOS phenotypes

Values of inflammation parameters - IL-6 in peripheral blood in the four PCOS phenotypes

Time Frame: up to 3 months

Measurement and comparison of concentrations of IL-6 (pg/ml) in peripheral blood in the four PCOS phenotypes

Values of inflammation parameters - C-reactive protein (CRP) in peripheral blood in the four PCOS phenotypes

Time Frame: up to 3 months

Measurement and comparison of concentrations of CRP (mg/l) in peripheral blood in the four PCOS phenotypes

Secondary Outcomes

  • Correlation between the homeostatic model assessment for insulin resistance (HOMA-IR) value and the parameters of inflammation - CRP in the four PCOS phenotypes(up to 3 months)
  • Correlation between the HOMA-IR value and the parameters of inflammation - TNF-alpha in the four PCOS phenotypes(up to 3 months)
  • Correlation between the value of AST concentration and the parameters of inflammation - il-1 in the four PCOS phenotypes(up to 3 months)
  • Correlation between the HOMA-IR value and the parameters of inflammation - il-6 in the four PCOS phenotypes(up to 3 months)
  • Correlation between the body mass index (BMI) value and the parameters of inflammation - leukocytosis in the four PCOS phenotypes(up to 3 months)
  • Correlation between the value of AST concentration and the parameters of inflammation - CRP in the four PCOS phenotypes(up to 3 months)
  • Correlation between the value of total bilirubin concentration and the parameters of inflammation - CRP in the four PCOS phenotypes(up to 3 months)
  • Correlation between the value of total cholesterol concentration and the parameters of inflammation - il-6 in the four PCOS phenotypes(up to 3 months)
  • Correlation between the value of triglycerides concentration and the parameters of inflammation - leukocytosis in the four PCOS phenotypes(up to 3 months)
  • Correlation between the value of Anti-Müllerian hormone (AMH) concentration and the parameters of inflammation - leukocytosis in the four PCOS phenotypes(up to 3 months)
  • Correlation between the HOMA-IR value and the parameters of inflammation - leukocytosis in the four PCOS phenotypes(up to 3 months)
  • Correlation between the BMI value and the parameters of inflammation - CRP in the four PCOS phenotypes(up to 3 months)
  • Correlation between the BMI value and the parameters of inflammation - il-6 in the four PCOS phenotypes(up to 3 months)
  • Correlation between the value of AST concentration and the parameters of inflammation - il-6 in the four PCOS phenotypes(up to 3 months)
  • Correlation between the value of AST concentration and the parameters of inflammation - il-10 in in the four PCOS phenotypes(up to 3 months)
  • Correlation between the value of ALT concentration and the parameters of inflammation - il-6 in the four PCOS phenotypes(up to 3 months)
  • Correlation between the value of ALT concentration and the parameters of inflammation - TNF-alpha in the four PCOS phenotypes(up to 3 months)
  • Correlation between the value of total cholesterol concentration and the parameters of inflammation - CRP in the four PCOS phenotypes(up to 3 months)
  • Correlation between the HOMA-IR value and the parameters of inflammation - il-1 in the four PCOS phenotypes(up to 3 months)
  • Correlation between the concentration of HOMA-IR and the parameters of inflammation - il-10 in in the four PCOS phenotypes(up to 3 months)
  • Correlation between the BMI value and the parameters of inflammation - il-1 in the four PCOS phenotypes(up to 3 months)
  • Correlation between the concentration of BMI and the parameters of inflammation - il-10 in in the four PCOS phenotypes(up to 3 months)
  • Correlation between the value of AST concentration and the parameters of inflammation - TNF-alpha in the four PCOS phenotypes(up to 3 months)
  • Correlation between the value of total bilirubin concentration and the parameters of inflammation - leukocytosis in the four PCOS phenotypes(up to 3 months)
  • Correlation between the value of total cholesterol concentration and the parameters of inflammation - leukocytosis in the four PCOS phenotypes(up to 3 months)
  • Correlation between the value of triglycerides concentration and the parameters of inflammation - TNF-alpha in the four PCOS phenotypes(up to 3 months)
  • Correlation between the BMI value and the parameters of inflammation - TNF-alpha in the four PCOS phenotypes(up to 3 months)
  • Correlation between the value of aspartate aminotransferase (AST) concentration and the parameters of inflammation - leukocytosis in the four PCOS phenotypes(up to 3 months)
  • Correlation between the value of alanine aminotransferase (ALT) concentration and the parameters of inflammation - leukocytosis in the four PCOS phenotypes(up to 3 months)
  • Correlation between the value of ALT concentration and the parameters of inflammation - CRP in the four PCOS phenotypes(up to 3 months)
  • Correlation between the value of total bilirubin concentration and the parameters of inflammation - il-1 in the four PCOS phenotypes(up to 3 months)
  • Correlation between the value of total bilirubin concentration and the parameters of inflammation - il-6 in the four PCOS phenotypes(up to 3 months)
  • Correlation between the value of total cholesterol concentration and the parameters of inflammation - il-10 in in the four PCOS phenotypes(up to 3 months)
  • Correlation between the value of triglycerides concentration and the parameters of inflammation - il-6 in the four PCOS phenotypes(up to 3 months)
  • Correlation between the value of triglycerides concentration and the parameters of inflammation - il-10 in in the four PCOS phenotypes(up to 3 months)
  • Correlation between the value of ALT concentration and the parameters of inflammation - il-1 in the four PCOS phenotypes(up to 3 months)
  • Correlation between the value of ALT concentration and the parameters of inflammation - il-10 in in the four PCOS phenotypes(up to 3 months)
  • Correlation between the value of total bilirubin concentration and the parameters of inflammation - il-10 in in the four PCOS phenotypes(up to 3 months)
  • Correlation between the value of total bilirubin concentration and the parameters of inflammation - TNF-alpha in the four PCOS phenotypes(up to 3 months)
  • Correlation between the value of total cholesterol concentration and the parameters of inflammation - il-1 in the four PCOS phenotypes(up to 3 months)
  • Correlation between the value of total cholesterol concentration and the parameters of inflammation - TNF-alpha in the four PCOS phenotypes(up to 3 months)
  • Correlation between the value of AMH concentration and the parameters of inflammation - CRP in the four PCOS phenotypes(up to 3 months)
  • Correlation between the value of AMH concentration and the parameters of inflammation - il-10 in in the four PCOS phenotypes(up to 3 months)
  • Correlation between the value of triglycerides concentration and the parameters of inflammation - CRP in the four PCOS phenotypes(up to 3 months)
  • Correlation between the value of triglycerides concentration and the parameters of inflammation - il-1 in the four PCOS phenotypes(up to 3 months)
  • Correlation between the value of AMH concentration and the parameters of inflammation - il-1 in the four PCOS phenotypes(up to 3 months)
  • Correlation between the value of AMH concentration and the parameters of inflammation - il-6 in the four PCOS phenotypes(up to 3 months)
  • Correlation between the value of AMH concentration and the parameters of inflammation - TNF-alpha in the four PCOS phenotypes(up to 3 months)

Study Sites (1)

Loading locations...

Similar Trials